Last week, the MISTRAL project celebrated its annual meeting, bringing together all partners to discuss advances in our shared mission. Over the past two days, partners shared and discussed the latest project achievements. Asphalion is honored to play a pivotal role as regulatory partners in this groundbreaking EU-funded initiative, which is exploring the crucial link between the gut microbiome and HIV/AIDS, specifically HIV-1.
The MISTRAL project aims to:
- Identify microbiome-related biomarkers to mitigate HIV infection.
- Enhance vaccine and therapy responsiveness.
- Develop an open-access database and cloud-based tools for research and clinical use.
This work aligns with our deep commitment to improving health outcomes.
Yesterday, as the world came together to mark World AIDS Day, we reaffirmed our commitment to driving innovation in the fight against HIV/AIDS and its associated clinical challenges. By deepening our understanding of the microbiome’s critical role in immune function, we aim to contribute to the development of enhanced therapies and transformative interventions for those living with HIV.
Together, we are working toward a healthier future. Check here for further information about the MISTRAL project: https://www.mistral-hiv.eu/the-project/
Are you working on an EU-funded project? Let’s collaborate! Contact us at [email protected]
